ABUS vs BEN
Arbutus Biopharma Corp (ABUS) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the ABUS and BEN stock pages for the full models.
Not investment advice.